DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Profit After Tax History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit After Tax | ₹2,191 Cr | ₹1,600 Cr | ₹1,824 Cr | ₹296,045 Cr | ₹1,984 Cr |
What is the latest Profit After Tax of DIVIS LABORATORIES ?
| Year | Profit After Tax |
|---|---|
| Mar2026 | ₹2,191 Cr |
| Mar2025 | ₹1,600 Cr |
| Mar2024 | ₹1,824 Cr |
| Mar2023 | ₹296,045 Cr |
| Mar2022 | ₹1,984 Cr |
How is Profit After Tax of DIVIS LABORATORIES Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,191 Cr | 36.94 | |
| Mar2025 | ₹1,600 Cr | -12.28 | |
| Mar2024 | ₹1,824 Cr | -99.38 | |
| Mar2023 | ₹296,045 Cr | 14,819.44 | |
| Mar2022 | ₹1,984 Cr | - | |
Compare Profit After Tax of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹193,406.1 Cr | 6.4% | 8.3% | 0.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,458.0 Cr | 2.8% | 7.4% | 14.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,829.0 Cr | 2.1% | 8.7% | 47.7% | Stock Analytics | |
| CIPLA | ₹116,164.0 Cr | 0.5% | 3.6% | -5.6% | Stock Analytics | |
| MANKIND PHARMA | ₹105,174.0 Cr | 1.7% | 6.4% | 4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,648.0 Cr | -7.6% | -2.2% | -5.8% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 6.4% |
8.3% |
0.7% |
| SENSEX | 0.9% |
2.2% |
-7.5% |
You may also like the below Video Courses